Product Information
CLONAZEPAM 0.25 MG ODT is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.4744 per EA under NDC 62332036506. Its NADAC has been published 347 times since Nov 6, 2019.
Strength
.25 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332036506
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA211033On Market Since
7/1/2019
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 0.25 MG ODT has been published 347 times since Nov 6, 2019, and over the history we have for it it has declined 32.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4744 per EA |
|---|---|
| All-time high | $0.8007 (May 11, 2022) |
| All-time low | $0.3522 (Jan 17, 2024) |
| 52-week high | $0.6792 |
| 52-week low | $0.4331 |
| Median price | $0.6178 |
| Average price | $0.5937 |
| Largest weekly change | +52.3% (Feb 21, 2024) |
| Weeks tracked | 347 |
| Tracking since | Nov 6, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the CLONAZEPAM market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CLONAZEPAM 0.25 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 0.25 MG ODT, manufactured by Alembic Pharmaceuticals Inc., is $0.4744 per EA (NDC 62332036506), effective Jun 24, 2026.
How has the price of CLONAZEPAM 0.25 MG ODT changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 0.25 MG ODT has declined 32.9%. It has been tracked across 347 weekly CMS publications since Nov 6, 2019.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 0.25 MG ODT?
Since Nov 6, 2019, the NADAC for CLONAZEPAM 0.25 MG ODT has ranged from a low of $0.3522 (Jan 17, 2024) to a high of $0.8007 (May 11, 2022), with a median of $0.6178 per EA.
Are there cheaper alternatives to CLONAZEPAM 0.25 MG ODT?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CLONAZEPAM 0.25 MG ODT, so no direct lower-cost alternative is listed.
Who manufactures CLONAZEPAM 0.25 MG ODT?
CLONAZEPAM 0.25 MG ODT (NDC 62332036506) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification